DocuSign, Inc.
DOCU
reported impressive third-quarter fiscal 2023 (ended Oct 31) results with both earnings and revenues surpassing the Zacks Consensus Estimate.
Non-GAAP earnings per share (excluding 72 cents from non-recurring items) of 57 cents beat the consensus mark by 39% but decreased 1.7% from the year-ago fiscal quarter’s reported figure. Revenues of $645.5 million also surpassed the Zacks Consensus Estimate by 3.1% and increased 18.3% from the year-ago fiscal quarter’s reported figure.
Shares of DocuSign have plunged 69.8% over the past year compared with 60.2% fall of the
industry
it belongs to.
Image Source: Zacks Investment Research
Quarter in Detail
Subscription revenues came in at $624.1 million, up 18% year over year. Professional services and other revenues surged 27% from the year-ago fiscal quarter’s reported figure to $21.4 million. International revenues increased 22.6% from the year-ago fiscal quarter’s reported figure and contributed 24.3% to total revenues. Billings of $659.4 million were up 17% from the year-ago fiscal quarter’s reported figure.
Non-GAAP gross margin was at 83% compared with 82% in the same period last year. Non-GAAP gross profit of $537.6 million increased 19.6% year over year. Non-GAAP operating margin of 20% declined from 22% reported in the year-ago quarter.
DocuSign ended the quarter with cash and cash equivalents of $632.6 million compared with $637.2 million at the end of the previous quarter. It generated $52.5 million of cash from operating activities and a capex of $16.5 million. Non-GAAP free cash flow was $36.1 million.
Guidance
For fourth-quarter fiscal 2023, DocuSign expects revenues in the range of $637-$641 million. The midpoint of the guided range ($639 million) is lower than the current Zacks Consensus Estimate of $639.6 million. Billings are expected to be between $705 million and $715 million. Non-GAAP gross margin is anticipated between 82% and 83%. Non-GAAP operating margin is expected between 20% and 22%.
For fiscal 2023, DocuSign expects revenues in the range of $2.493-$2.497 billion (prior guidance was $2.47-$2.482 billion). The midpoint of the guided range ($2.495 billion) is above the Zacks Consensus Estimate of $2.48 billion. Billings are expected to be between $2.626 billion and $2.636 billion. Non-GAAP gross margin is anticipated between 81% and 82%. Non-GAAP operating margin is expected between 18% and 20%.
DocuSign currently carries a Zacks Rank #3 (Hold).You can see
the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
DocuSign Price, Consensus and EPS Surprise
DocuSign price-consensus-eps-surprise-chart
|
DocuSign Quote
Recent Releases
Omnicom Group Inc.
OMC
reported impressive third-quarter 2022 results, wherein both earnings and revenues surpassed the respective Zacks Consensus Estimate.
Earnings of $1.77 per share beat the Zacks Consensus Estimate by 7.9% and increased 7.3% year over year, driven by a solid margin performance. Total revenues of $3.4 billion surpassed the Zacks Consensus Estimate by 3% and increased slightly on a year-over-year basis.
Equifax Inc.
EFX
reported stellar third-quarter 2022 results, wherein both earnings and revenues surpassed the respective Zacks Consensus Estimate.
Adjusted earnings (excluding 39 cents from non-recurring items) of $1.73 per share beat the Zacks Consensus Estimate by 5.5% but decreased 6.5% on a year-over-year basis. However, revenues of $1.24 billion beat the Zacks Consensus Estimate by 2.3% and improved 1.8% year over year on a reported basis and 4% on a local-currency basis.
The Interpublic Group of Companies, Inc.
IPG
reported better-than-expected third-quarter 2022 results.
Adjusted earnings (excluding a penny from non-recurring items) of 63 cents per share beat the Zacks Consensus Estimate by 6.8%. The bottom line has been flat over the past year. Net revenues of $2.3 billion beat the consensus estimate by 0.3% but declined 9.7% on a year-over-year basis. Total revenues of $2.64 billion increased 3.8% year over year.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
